Cost thresholds for anticipated long‐acting HIV pre‐exposure prophylaxis products in Eastern and Southern Africa: a mathematical modelling study
David Kaftan(New York University Florence), Anna Bershteyn(New York University), Linxuan Wu(University of Washington), Danielle Resar(Clinton Health Access Initiative), Masabho Milali(New York University), Ingrida Platais(New York University), Cory Arrouzet(University of Washington), Hae‐Young Kim(New York University), Monisha Sharma(University of Washington), Sarah Yardly Jenkins(Clinton Health Access Initiative), Edinah Mudimu(University of South Africa)
Cited by 10
Related Papers
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
|PLoS Medicine|2012|406
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection
|Annals of Internal Medicine|2020|93
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
|JAMA Network Open|2022|92